Open Access
Open access
PLoS ONE, volume 16, issue 3, pages e0247640

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma

For Yue Tso 1
Salum J. Lidenge 1
Lisa K. Poppe 1
Phoebe B Peña 1
Sara R Privatt 1
Sydney J Bennett 1
John R Ngowi 2
Julius Mwaiselage 3
Michael Belshan 1
Jacob A. Siedlik 4
Morgan A Raine 5
Juan B. Ochoa 6
Julia Garcia-Diaz 7
Bobby Nossaman 7
Lyndsey Buckner 7
W. Mark Roberts 7
Matthew J. Dean 8
Augusto C. Ochoa 9
John T. West 1
Charles C. Wood 1
1
 
Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States of America,
2
 
Ocean Road Cancer Institute, Dar Es Salaam, Tanzania
3
 
Ocean Road Cancer Institute, Dar es Salaam, Tanzania,
4
 
Department of Exercise Science and Pre-Health Professions, Creighton University, Omaha, NE, United States of America
5
 
Department of Medical Microbiology & Immunology, Creighton University, Omaha, NE, United States of America
6
 
Department of Surgery, Ochsner Medical Center, New Orleans, LA, United States of America
7
 
Department of Internal Medicine Ochsner Medical Center, New Orleans, LA, United States of America
8
 
Louisiana State University Cancer Center, New Orleans, LA, United States of America
9
 
Louisiana State University Cancer Center, New Orleans, LA, United States of America,
Publication typeJournal Article
Publication date2021-03-04
Journal: PLoS ONE
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor3.7
ISSN19326203, 19326203
Multidisciplinary
Abstract
Background

Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune responses, it is possible that antibodies could also mediate protection against SARS-CoV-2 via effector mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), which we sought to explore here.

Methods

Plasma of 3 uninfected controls and 20 subjects exposed to, or recovering from, SARS-CoV-2 infection were collected from U.S. and sub-Saharan Africa. Immunofluorescence assay was used to detect the presence of SARS-CoV-2 specific IgG antibodies in the plasma samples. SARS-CoV-2 specific neutralizing capability of these plasmas was assessed with SARS-CoV-2 spike pseudotyped virus. ADCC activity was assessed with a calcein release assay.

Results

SARS-CoV-2 specific IgG antibodies were detected in all COVID-19 subjects studied. All but three COVID-19 subjects contained nAb at high potency (>80% neutralization). Plasma from 19/20 of COVID-19 subjects also demonstrated strong ADCC activity against SARS-CoV-2 spike glycoprotein, including two individuals without nAb against SARS-CoV-2.

Conclusion

Both neutralizing and non-neutralizing COVID-19 plasmas can mediate ADCC. Our findings argue that evaluation of potential vaccines against SARS-CoV-2 should include investigation of the magnitude and durability of ADCC, in addition to nAb.

Top-30

Citations by journals

1
2
3
4
5
6
Frontiers in Immunology
6 publications, 11.32%
Journal of Medical Virology
3 publications, 5.66%
Signal Transduction and Targeted Therapy
2 publications, 3.77%
Scientific Reports
2 publications, 3.77%
Cell Reports
2 publications, 3.77%
Journal of Infectious Diseases
2 publications, 3.77%
Vaccines
2 publications, 3.77%
JCI insight
1 publication, 1.89%
Reviews in Medical Virology
1 publication, 1.89%
Medicina
1 publication, 1.89%
Nature
1 publication, 1.89%
JAAD Case Reports
1 publication, 1.89%
Immunity
1 publication, 1.89%
Journal of Virological Methods
1 publication, 1.89%
Genetics in Medicine
1 publication, 1.89%
Transfusion Medicine Reviews
1 publication, 1.89%
EBioMedicine
1 publication, 1.89%
Cell Reports Medicine
1 publication, 1.89%
Journal of Immunological Methods
1 publication, 1.89%
Cytometry. Part A : the journal of the International Society for Analytical Cytology
1 publication, 1.89%
Immunological Reviews
1 publication, 1.89%
Journal of Biomolecular Structure and Dynamics
1 publication, 1.89%
Science immunology
1 publication, 1.89%
Emerging Microbes and Infections
1 publication, 1.89%
Life Sciences
1 publication, 1.89%
Pathogens
1 publication, 1.89%
Plant Biotechnology Journal
1 publication, 1.89%
Antiviral Research
1 publication, 1.89%
Frontiers of Medicine
1 publication, 1.89%
1
2
3
4
5
6

Citations by publishers

2
4
6
8
10
12
Elsevier
12 publications, 22.64%
Wiley
7 publications, 13.21%
Springer Nature
7 publications, 13.21%
Frontiers Media S.A.
6 publications, 11.32%
Cold Spring Harbor Laboratory
6 publications, 11.32%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 9.43%
Oxford University Press
2 publications, 3.77%
American Society for Clinical Investigation
1 publication, 1.89%
Taylor & Francis
1 publication, 1.89%
American Association for the Advancement of Science (AAAS)
1 publication, 1.89%
Higher Education Press
1 publication, 1.89%
Bentham Science
1 publication, 1.89%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.89%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Tso F. Y. et al. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma // PLoS ONE. 2021. Vol. 16. No. 3. p. e0247640.
GOST all authors (up to 50) Copy
Tso F. Y., Lidenge S. J., Poppe L. K., Peña P. B., Privatt S. R., Bennett S. J., Ngowi J. R., Mwaiselage J., Belshan M., Siedlik J. A., Raine M. A., Ochoa J. B., Garcia-Diaz J., Nossaman B., Buckner L., Roberts W. M., Dean M. J., Ochoa A. C., West J. T., Wood C. C. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma // PLoS ONE. 2021. Vol. 16. No. 3. p. e0247640.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1371/journal.pone.0247640
UR - https://doi.org/10.1371/journal.pone.0247640
TI - Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
T2 - PLoS ONE
AU - Tso, For Yue
AU - Lidenge, Salum J.
AU - Poppe, Lisa K.
AU - Peña, Phoebe B
AU - Privatt, Sara R
AU - Bennett, Sydney J
AU - Ngowi, John R
AU - Mwaiselage, Julius
AU - Belshan, Michael
AU - Siedlik, Jacob A.
AU - Raine, Morgan A
AU - Ochoa, Juan B.
AU - Garcia-Diaz, Julia
AU - Nossaman, Bobby
AU - Buckner, Lyndsey
AU - Roberts, W. Mark
AU - Dean, Matthew J.
AU - Ochoa, Augusto C.
AU - West, John T.
AU - Wood, Charles C.
PY - 2021
DA - 2021/03/04 00:00:00
PB - Public Library of Science (PLoS)
SP - e0247640
IS - 3
VL - 16
SN - 1932-6203
SN - 1932-6203
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Tso,
author = {For Yue Tso and Salum J. Lidenge and Lisa K. Poppe and Phoebe B Peña and Sara R Privatt and Sydney J Bennett and John R Ngowi and Julius Mwaiselage and Michael Belshan and Jacob A. Siedlik and Morgan A Raine and Juan B. Ochoa and Julia Garcia-Diaz and Bobby Nossaman and Lyndsey Buckner and W. Mark Roberts and Matthew J. Dean and Augusto C. Ochoa and John T. West and Charles C. Wood},
title = {Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma},
journal = {PLoS ONE},
year = {2021},
volume = {16},
publisher = {Public Library of Science (PLoS)},
month = {mar},
url = {https://doi.org/10.1371/journal.pone.0247640},
number = {3},
pages = {e0247640},
doi = {10.1371/journal.pone.0247640}
}
MLA
Cite this
MLA Copy
Tso, For Yue, et al. “Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.” PLoS ONE, vol. 16, no. 3, Mar. 2021, p. e0247640. https://doi.org/10.1371/journal.pone.0247640.
Found error?